Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Document › Details

Unchained Labs. (6/29/17). "Press Release: Unchained Labs Racks Up another One, Acquires Trinean!". Pleasanton, CA.

Organisation Organisation Trinean N.V.
  Today Unchained Labs Belgium
Product Product  laboratory equipment and instruments
Index terms Index term Trinean–Unchained Labs: investment, 201706 acquisition of Trinean by Unchained Labs
  Index term 2 Unchained Labs–SEVERAL: investment, 201706 financing round Series C $13m incl existing investors Novo Ventures + Canaan Partnes + TPG Biotech
Person Person Harkness, Tim (Cell Biosciences 200909 CEO)
     


Unchained Labs, the life sciences company that's all about getting biologics researchers the right tool for the job, acquired Trinean today. Trinean's DropSense systems measure protein, DNA and RNA concentration in biologics and genomics samples. This is Unchained Labs' 5th acquisition in just over 2 years.

DropSense96 is the only system out there that can measure up to 96 high concentration protein samples in 5 minutes. Scientists just load 2 microliters of sample into the proprietary DropPlate, put it in the system and that's it. DropSense systems are a completely worry-free way to measure concentrations — no need to dilute or mix samples, clean anything before or after a run, or calibrate the system.

"Since it started 10 years ago, Trinean has made micro-volume concentration measurements higher throughput and more accessible to life science researchers," said Philippe Stas, CEO of Trinean. "Unchained Labs is the ideal home for DropSense and this acquisition is great for our customers, partners and employees."

"These products are a perfect strategic fit for Unchained Labs," said Tim Harkness, Founder and CEO of Unchained Labs. "Concentration measurement is central to everything our customers do and DropSense96 is the only product in the world that does it for biologics at high concentration with high-throughput."

In just over 2 years, Unchained Labs has grown to over 130 employees, $35M+ in revenue, 8 product lines and has direct distribution around the world. In connection with this transaction, the company raised $13M in a Series C financing. The original syndicate partners, Novo Ventures, Canaan Partners and TPG Biotech all participated in the financing.


About Unchained Labs

Here's the deal. We're all about helping biologics researchers break free from tools that just don't cut it. Unleashing problem-tackling products that make a huge difference in the real science they do every day. That's our mantra, our promise and we own it. We're located in Pleasanton, CA and can be found online at www.unchainedlabs.com.


Contact:

Taegen Clary
VP of Marketing, Unchained Labs
taegen.clary@unchainedlabs.com
925.587.9806

   
Record changed: 2023-06-05

Advertisement

Picture Bionter Seeing Things witzh EVE the Particle Counter 650x200px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px




» top